Capital Markets: Equity (International Firms) - China
Band 3
What the Team is Known For
With noted specialist strengths advising clients in the healthcare, life sciences, technology and biotechnology sectors, O'Melveny & Myers regularly handles Hong Kong IPOs, advising both issuers and sponsors. The team is also equipped to handle H-share listings and listing transfers.
Strengths
O'Melveny & Myers is a trusted firm for Hong Kong IPOs and has professional competence in the market.
Work Highlights
O'Melveny & Myers advised Laopu Gold on its approximately USD116 million initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.
Notable practitioners
Geng Ke is head of O'Melveny & Myers' China capital markets team and managing partner of the firm's Beijing office. He regularly leads a range of listings across the biopharmaceutical, healthcare and life sciences sectors.
Zhu Ke is dual-qualified in New York and Hong Kong and is consistently called on to handle a range of healthcare, technology and life sciences equity capital markets transactions.
